Novelis, Inc. is a privately held company with proprietary ultrasonic visualization and therapy technology for minimally invasive diagnostic and therapeutic devices.
Medivir appoints chief medical officer
The Jacobus Report
How PET and SPECT are reinventing the way we evaluate and image the brain
Resources for Cancer Patients and Referring Physicians Through New, Redesigned Website.
Get to know the director of the Center for Molecular Imaging and Nanotechnology at Memorial Sloan Kettering Cancer Center
Improving the selection of trial sites, accelerate enrollment
University of Bristol (UB) Professors Alan Preece and Dr. Ian Craddock are developing a device which uses radio waves to detect breast cancer that are unlike conventional mammograms which use radiation.
The 56th SNM Annual Meeting will be held June 13-17, 2009, in Toronto, Canada; visit DOTmed in Booth #511.
VitalCare Diabetes Treatment Centers, Inc. (VitalCare) will offer licenses, moving their patented and FDA approved Intracellular Activation Therapy (iCAT) to market.
Caris Life Sciences hires researcher and clinical oncologist as Chief Medical Officer
PET's diagnostic possibilities are almost limitless, so what's holding it back? -- An interview with Dr. Henry Wagner, Jr.
The future of CR and DR detectors
Biotronik's new implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator provide continuous wireless home monitoring of cardiac patients to doctors around the world.
Providers need access to better fluid analysis tools
More than half will be moved to new Cambridge headquarters
Increasingly utilized in staging liver fibrosis noninvasively
Insights from Murat Gungor, vice president of Magnetic Resonance (MR) at Siemens Healthineers North America
Radiotherapy and radiosurgery treatments have been delivered for prostate cancer, lung cancer, schwannomas, brain and spinal metastases.
64Cu-Dotatate for use in suspected neuroendocrine tumors
Of 1,298 senior men only two died of the disease, three had metastases
Researchers relied on PET and SPECT to monitor and verify the effectiveness of life-saving new therapy, according to The Journal of Nuclear Medicine.
Study finds it more effective than conventional methods
